Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2002
08/06/2002US6429224 Use of taurolidine to treat tumors
08/06/2002US6429222 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents
08/06/2002US6429206 Using agonist of nicotinergic acetylcholine receptors
08/01/2002WO2002059267A2 Constitutively desensitized g protein-coupled receptors
08/01/2002WO2002059098A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
08/01/2002WO2002059074A1 Benzylamine analogue
08/01/2002WO2002058730A2 Compositions for treatment of ocular neovascularization
08/01/2002WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002WO2002058656A1 Novel couplers for use in oxidative hair dyeing
08/01/2002WO2002058655A1 Novel couplers for use in oxidative hair dyeing
08/01/2002WO2002058654A1 Primary intermediates for oxidative coloration of hair
08/01/2002WO2002058653A1 Primary intermediates for oxidative coloration of hair
08/01/2002WO2002058632A2 Primary intermediates for oxidative coloration of hair
08/01/2002WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof
08/01/2002WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
08/01/2002WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands
08/01/2002US20020103380 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002US20020103235 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
08/01/2002US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same
08/01/2002US20020103202 Heteroaryl-phenyl substituted factor Xa inhibitors
08/01/2002US20020103182 Improving elasticity or reducing wrinkles of a skin, for example; advanced glycosylation endproducts" or AGEs
08/01/2002US20020102597 Methods for selecting compounds for treating ischemia-related cellular damage
08/01/2002US20020102433 Oxadizaole tetramers
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
08/01/2002US20020102235 Novel imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus
08/01/2002CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2435883A1 Benzylamine analogue
08/01/2002CA2435047A1 Constitutively desensitized g protein-coupled receptors
08/01/2002CA2433836A1 Novel couplers for use in oxidative hair dyeing
08/01/2002CA2431634A1 Primary intermediates for oxidative coloration of hair
08/01/2002CA2431611A1 Primary intermediates for oxidative coloration of hair
07/2002
07/31/2002EP1227144A1 Oil-soluble additive compositions for lubricating oils comprising imidazolidine thione
07/31/2002EP1227086A1 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
07/31/2002EP1227085A1 Process for producing optically active naphthalene derivative and optical resolver therefor
07/31/2002EP1226435A1 Axor35, a g-protein coupled receptor
07/31/2002EP1226124A1 Heterocyclically substituted benzoylguanidine, method for the production thereof, the use thereof as a medicament or means of diagnosis and a medicament containing the same
07/31/2002EP1226111A1 Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP1060165A4 Method for preparing n-substituted heterocyclic derivatives using a phase-transfer catalyst
07/31/2002CN1361716A Preparation and use of ionic liquids in microwave-assisted chemical transformation
07/31/2002CN1361688A Nitroimidazole external preparations for dermatosis
07/30/2002US6426424 Heating hydrated metal sulfate salt, an amino acid ligand and a reaction modifier in an enclosed environment, ligand to metal molar ratio is from 1:1-4:1
07/30/2002US6426408 Plurality of nucleotide units with linking group
07/30/2002US6426360 Antiarthritic agents
07/30/2002US6426348 For therapy of inflammation associated with chronic inflammatory diseases such as rheumatoid arthritis (ra), multiple sclerosis, (ms), asthma, and inflammatory bowel disease (i bd)
07/30/2002CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives
07/30/2002CA2110806C 4-(1h-pyrrol-1-yl)imidazoles with angiotensin ii antagonist activity
07/30/2002CA2054342C Azolylmethylspiro [2.5] octanols and fungicides containing these
07/25/2002WO2002057269A1 Synthesis of temozolomide and analogs
07/25/2002WO2002057268A1 Synthesis of temozolomide and analogs
07/25/2002WO2002057252A2 Heterocyclic sulfonamide inhibitors of beta amyloid production
07/25/2002WO2002057233A1 Mch antagonists and their use in the treatment of obesity
07/25/2002WO2002057215A2 Sodium channel modulators
07/25/2002WO2002056827A2 Substituted felbamate derived compounds
07/25/2002WO2002030947A3 Compositions and methods of preparing amino acid chelates and complexes
07/25/2002WO2001088160A3 Vectors for dna delivery
07/25/2002US20020099225 Efficient ligand-mediated ullmann coupling of anilnies and azoles
07/25/2002US20020099222 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
07/25/2002US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
07/25/2002US20020099074 Novel anilide compounds and drugs containing the same
07/25/2002US20020098999 Compounds for sustained release of orally delivered drugs
07/25/2002US20020098556 Generating preferential compound in culture; obtain genetically engineered bacteria, culturing, recover preferential compound
07/25/2002US20020098242 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
07/25/2002CA2434300A1 Synthesis of temozolomide and analogs
07/25/2002CA2427058A1 Substituted felbamate derived compounds
07/24/2002EP1225170A2 Cycloheptene compounds, process for their preparation and pharmaceutical compositions containing them
07/24/2002EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method
07/24/2002EP1224171A1 Beta disubstituted metalloprotease inhibitors
07/24/2002EP1224165A1 Novel compounds
07/24/2002EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
07/24/2002EP1223931A1 Treatment or prevention of hypotension and shock
07/24/2002EP1223916A2 Neutral-cationic lipid for nucleic acid and drug delivery
07/24/2002EP0689463B1 Imidazole based nitrogen-sulfur ligands useful in radiographic imaging agents
07/24/2002EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors
07/24/2002CN1360580A Substd. benzoyl ketones, methods for producing them and their use as herbicides
07/24/2002CN1360573A Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same
07/24/2002CN1360568A Diacylhydrazine derivs.
07/24/2002CN1088062C Certain 4-aminomethy-2-substd. imidazole derivs. and 2-aminomethyl-4-substd. imidazole derivs. new classes of dopamine receptor subtype specific ligands
07/24/2002CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates
07/23/2002US6423728 Heterocyclic thioamide derivatives
07/23/2002US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
07/23/2002US6423709 Methods of using novel compounds as neuro-protective agents
07/23/2002US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides
07/23/2002US6423707 Nitroimidazole ester analogues and therapeutic applications
07/23/2002US6423690 Antibacterial agents
07/18/2002WO2002055506A1 Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop
07/18/2002WO2002055505A1 Process for producing 1,3-dialkyl-2-imidazolidinone compound
07/18/2002WO2002055025A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
07/18/2002WO2002032876A3 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
07/18/2002WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof
07/18/2002WO2002012224A3 Bicyclic compounds as h3 receptor ligands
07/18/2002WO2002008198A3 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus
07/18/2002WO2002003912A3 Novel c-4 substituted retinoids
07/18/2002WO2001094318A3 Method for synthesis of substituted azole libraries
07/18/2002WO2001072728A3 Novel piperazine derivatives
07/18/2002WO2001072715A3 N-halamine vinyl compounds and their polymeric biocides
07/18/2002WO2001072685A3 Polyamine analogues as cytotoxic agents